EASTPHARMA LTD.
London, 2 March 2018 - EastPharma (EAST LI) informs that it will be releasing its audited financial statements for the year ended 31 December 2017 and a review of its main subsidiary DEVA Holding's audited financial statements for the related period on 9 March 2018.
A conference call to review the financial performance for the year ended 31 December 2017 will be hosted by the management of EastPharma at 12:00-noon London time on 12 March 2018 (08:00am New York time / 01:00-pm Zurich time / 03:00pm Istanbul time). The dial-in details are provided below.
Conference call:
Dial-in Number (UK): 08003767425 Dial-in Number (US): 18668692321 Dial-in Number (Switzerland): 0800740368 Dial-in Number (Germany): 08000007416
Conference ID: 3178578
For further information, please contact: Investor Relations:
email: ir@eastpharma.com
EastPharma Ltd - a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets; for further information please visit www.eastpharma.com.
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: EastPharma Ltd via GlobeNewswire
B1ZBJ18R53
Copyright RTT News/dpa-AFX